Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
allogeneic cell therapy
Biotech
Adicet Bio CAR-T sparks lupus remissions in early-stage trial
Adicet's prula-cel sent more than half of patients’ lupus into remission, without the dangerous side effects that recently rocked Big Pharma.
Darren Incorvaia
Sep 28, 2026 6:45am
Cellectis cans allogeneic CAR-Ts to hop aboard in vivo bandwagon
Sep 14, 2026 5:26am
Caribou boosts case for off-the-shelf CAR-T v. autologous
Jun 11, 2026 8:00am
ASCO: Legend scientific founder returns with new CAR-T ambition
May 29, 2026 2:00pm
Allogene’s off-the-shelf CAR-T erases lingering lymphoma cells
Apr 13, 2026 7:45am
Sana shares 14-month data for ‘functional cure’ diabetes program
Mar 13, 2026 10:55am
